"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,EP,A1,EP 1677817 A1,048-852-315-112-018,2006-07-12,2006,EP 04789111 A,2004-09-27,US 2004/0031704 W;;US 69457903 A,2003-10-27,G-CSF THERAPY AS AN ADJUNCT TO REPERFUSION THERAPY IN THE TREATMENT OF ACUTE MYOCARDIAL INFARCTION,,UNIV NORTHWESTERN,MEHTA JAYESH;;SINGHAL SEEMA;;DAVIDSON CHARLES;;BEOHAR NIRAT;;BONOW ROBERT,,https://lens.org/048-852-315-112-018,Patent Application,yes,0,0,7,7,0,A61K38/193;;A61P9/10;;A61K38/193,A61K38/19;;A61K38/27,,0,0,,,,DISCONTINUED
2,WO,A1,WO 2005/044296 A1,069-559-120-798-987,2005-05-19,2005,US 2004/0031704 W,2004-09-27,US 69457903 A,2003-10-27,G-CSF THERAPY AS AN ADJUNCT TO REPERFUSION THERAPY IN THE TREATMENT OF ACUTE MYOCARDIAL INFARCTION,The present invention relates to methods of using Granulocyte Colony Stimulating Factor (G-CSF) polypeptide in conjunction with reperfusion therapy in the treatment of acute myocardial infarction or other ischemic events. This treatment can be used alone or in combination with other well-known methods of treatment.,UNIV NORTHWESTERN;;MEHTA JAYESH;;SINGHAL SEEMA;;DAVIDSON CHARLES;;BEOHAR NIRAT;;BONOW ROBERT,MEHTA JAYESH;;SINGHAL SEEMA;;DAVIDSON CHARLES;;BEOHAR NIRAT;;BONOW ROBERT,,https://lens.org/069-559-120-798-987,Patent Application,yes,4,2,7,7,0,A61K38/193;;A61P9/10;;A61K38/193,A61K38/19;;A61K38/27,,11,7,113-368-446-882-793;;032-695-258-386-735;;054-516-724-546-575;;013-743-141-808-45X;;015-862-696-993-972;;102-905-320-385-62X;;038-982-730-833-077,10.1096/fasebj.17.3.532;;10.1016/s1567-5688(03)90868-3;;10.1073/pnas.181177898;;pmc56963;;11504914;;10.1182/blood.v92.1.68.413k23_68_75;;9639501;;10.1023/a:1024765500179;;12878832;;11010376;;10.1016/s1067-991x(00)90071-3;;15123535;;10.1161/01.cir.0000129770.93985.3e,"MINATOGUCHI SHINYA ET AL: ""Myocardial infarction itself induces cardiomyocyte regeneration from bone marrow cells, and post-ischemic G-CSF treatment improves cardiac dysfunction via acceleration of the process."", CIRCULATION, vol. 106, no. 19 Supplement, 5 November 2002 (2002-11-05), & ABSTRACTS FROM SCIENTIFIC SESSIONS; CHICAGO, IL, USA; NOVEMBER 17-20, 2002, pages II - 132, XP009042568, ISSN: 0009-7322;;AMBLER S KELLY ET AL: ""Integration of bone marrow-derived stem cells into infarcted myocardium following ischemia-reperfusion in mice."", FASEB JOURNAL, vol. 17, no. 4-5, March 2003 (2003-03-01), & FASEB MEETING ON EXPERIMENTAL BIOLOGY: TRANSLATING THE GENOME; SAN DIEGO, CA, USA; APRIL 11-15, 2003, pages Abstract No. 413.7 URL - http://ww, XP009042567, ISSN: 0892-6638;;LI Y ET AL: ""Efficiency of granulocyte colony stimulating factor (G-CSF) on cardiac function and cytokines in rat model of acute myocardial infarction"", ATHEROSCLEROSIS SUPPLEMENTS, vol. 4, no. 2, September 2003 (2003-09-01), ELSEVIER SCI IRELAND LTD, pages 204, XP002314188, ISSN: 1567-5688;;KURAMOCHI YUKIO ET AL: ""Granulocyte-colony stimulating factor (G-CSF) administeration improves cardiac function after myocardial infarction in mice without altering cardiomyocyte regeneration."", CIRCULATION, vol. 106, no. 19 Supplement, 5 November 2002 (2002-11-05), & ABSTRACTS FROM SCIENTIFIC SESSIONS; CHICAGO, IL, USA; NOVEMBER 17-20, 2002, pages II - 20, XP009042609, ISSN: 0009-7322;;ORLIC D ET AL: ""Mobilized bone marrow cells repair the infarcted heart, improving function and survival"", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 98, no. 18, 28 August 2001 (2001-08-28), pages 10344 - 10349, XP002216659, ISSN: 0027-8424;;HELLSTRÖM-LINDBERG E ET AL: ""Treatment of anemia in myelodysplastic syndromes with granulocyte colony-stimulating factor plus erythropoietin: results from a randomized phase II study and long-term follow-up of 71 patients."", BLOOD. 1 JUL 1998, vol. 92, no. 1, 1 July 1998 (1998-07-01), pages 68 - 75, XP002314189, ISSN: 0006-4971;;SCHWARTZ YITZHACK ET AL: ""Autologous stem cells for functional myocardial repair."", HEART FAILURE REVIEWS. JUL 2003, vol. 8, no. 3, July 2003 (2003-07-01), pages 237 - 245, XP002314190, ISSN: 1382-4147;;GOLTERMANN J: ""Reperfusion of acute coronary syndromes and myocardial infarction"", AIR MEDICAL JOURNAL, MOSBY, vol. 19, no. 2, April 2000 (2000-04-01), pages 47 - 49, XP004530163, ISSN: 1067-991X;;MEHTA JAYESH ET AL: ""Early administration of filgrastim following experimental myocardial infarction in a porcine ischemia reperfusion model may help myocardial repair."", BLOOD, vol. 102, no. 11, 16 November 2003 (2003-11-16), & 45TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF HEMATOLOGY; SAN DIEGO, CA, USA; DECEMBER 06-09, 2003, pages 154b - 155b, XP009042504, ISSN: 0006-4971;;MINATOGUCHI SHINYA ET AL: ""Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment"", CIRCULATION, vol. 109, no. 21, 1 June 2004 (2004-06-01), pages 2572 - 2580, XP009042569, ISSN: 0009-7322;;ENGELMANN MARKUS G ET AL: ""Placebo-controlled, randomized, double-blind study on the efficacy of bone-marrow stem cell mobilization induced by granulocyte-colony stimulating factor (G-CSF) on improvement of ischemic heart failure undergoing delayed revascularization for ST segment elevation myocardial infarction (STEMI)."", CIRCULATION, vol. 108, no. 17 Supplement, 28 October 2003 (2003-10-28), & AMERICAN HEART ASSOCIATION SCIENTIFIC SESSIONS 2003; ORLANDO, FL, USA; NOVEMBER 09-12, 2003, pages IV - 622, XP009042559, ISSN: 0009-7322",PENDING
3,US,B2,US 7220407 B2,021-667-319-657-635,2007-05-22,2007,US 69457903 A,2003-10-27,US 69457903 A,2003-10-27,G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction,The present invention relates to methods of using Granulocyte Colony Stimulating Factor (G-CSF) polypeptide in conjunction with reperfusion therapy in the treatment of acute myocardial infarction or other ischemic events. This treatment can be used alone or in combination with other well-known methods of treatment.,UNIV NORTHWESTERN,MEHTA JAYESH;;SINGHAL SEEMA;;DAVIDSON CHARLES;;BEOHAR NIRAT;;BONOW ROBERT,NORTHWESTERN UNIVERSITY (2003-10-23),https://lens.org/021-667-319-657-635,Granted Patent,yes,46,22,7,7,0,A61K38/193;;A61P9/10;;A61K38/193,A61K38/19;;A61K38/18;;A61K38/20;;A61K38/27;;A61K45/00,424/85.1;;424/85.2;;435/1.2;;514/12,37,29,012-221-693-955-779;;031-982-965-285-365;;112-003-961-947-901;;007-498-512-937-952;;006-639-103-092-370;;084-588-472-298-181;;032-321-978-707-262;;033-640-803-640-304;;066-290-655-735-589;;015-612-958-616-068;;071-648-319-312-389;;025-506-364-728-912;;003-631-876-084-094;;065-488-184-593-71X;;008-663-530-046-654;;082-832-232-437-495;;001-865-718-003-526;;123-676-259-156-005;;054-516-724-546-575;;003-458-259-072-219;;125-777-637-347-753;;022-860-347-897-442;;009-764-183-234-413;;023-499-881-997-55X;;102-905-320-385-62X;;013-743-141-808-45X;;032-695-258-386-735;;038-982-730-833-077;;015-862-696-993-972,10.1067/mtc.2002.123133;;12324734;;10.1002/path.878;;11400155;;10415551;;10.1111/j.1749-6632.1999.tb09255.x;;10.1161/01.cir.93.7.1447;;8641035;;7814650;;10.1172/jci117680;;pmc295378;;7506461;;10.1126/science.279.5356.1528;;9488650;;7691413;;10.1016/0092-8674(93)90729-a;;2658099;;1378868;;2645965;;10.1016/s0950-3536(89)80009-5;;10.1038/86498;;11283669;;2466458;;10.1016/0006-291x(89)92410-8;;7693904;;10.1016/s0022-3476(05)80403-2;;10.1056/nejm200203283461302;;11919303;;10.1016/0003-9861(89)90567-5;;2463792;;pmc299244;;10.1073/pnas.84.20.7134;;3499607;;11287958;;10.1038/35070587;;10.1073/pnas.181177898;;pmc56963;;11504914;;12799293;;10.1111/j.1749-6632.2003.tb03243.x;;10.1126/science.2420009;;10.1126/science.232.4746.61;;2420009;;12769752;;10.2174/1381612033455008;;10.1073/pnas.82.5.1526;;pmc397296;;3871951;;7534323;;10.1016/s0168-8278(94)80262-9;;11010376;;10.1016/s1067-991x(00)90071-3;;10.1182/blood.v92.1.68.413k23_68_75;;9639501;;10.1016/s1567-5688(03)90868-3;;15123535;;10.1161/01.cir.0000129770.93985.3e;;10.1023/a:1024765500179;;12878832,"Vallely et al., The J of Thoracic and Cardiovascular Surgery, vol. 124(4): pp. 758-767, esp. p. 761, Figure 1.;;Hiltunen, et al. Nerve growth factor and brain-derived neurotrophic factor mRNAs are regulated in distinct cell populations of rat heart after ischaemia and reperfusion. J Pathol. Jun. 2001;194(2):247-53.;;Gottlieb et al., Apoptosis in myocardial ischemia-reperfusion. Ann N Y Acad Sci. Jun. 30, 1999;874:412-26. Review.;;Melillo et al., Intrinsic Myocyte Dysfunction and Tryrosine Kinase Pathway Activation Underlie the Imparied Wall Thickening of Adjacent Regions During Postinfarct Left Venricular Remodeling. 1996 Circulation 93:1447-58.;;Stedman's Medical Dictionary 27th Edition, 2000 Lippincott Williams & Wilkins.;;Kukielka et al., Interleukin-8 Gene Induction in the Myocardium after Ischemia and Reperfusion in Vivo. J Clin Invest. Jan. 1995 95:89-103.;;Colquhoun et al., Reversal of neutropenia with granulocyte colony-stimulating factor without precipitating liver allograft rejection, Transplantation 56:755-758, 1993.;;Diflo et al., Simultaneous use of ganciclovir and granulocyte colony stimulating factor in liver transplant recipients, Hepatology 16:PA278A, 1992.;;Ferrari, et al., Muscle regeneration by bone marrow-derived myogenic progenitors, Science 279:1528-1530, 1998.;;Fukunaga et al., Growth and differentiation signals mediated by different regions in the cytoplasmic domain of granulocyte colony-stimulating factor receptor, Cell 74:1079-1087, 1993.;;Gabrilove, Introduction and overview of hematopoietic growth factors, Semin. Hematol. 26:2 (Suppl 2):1-4, 1989.;;Görgen et al., Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-alpha, J. Immunol. 149:918-924, 1992.;;Jones et al., Growth factors in haemopoiesis, Bailliere's Clin. Hematol. 2:83-111, 1989.;;Kocher et al., Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function, Nature Med. 7:430-436, 2001.;;Kuga et al., Mutagenesis of human granulocyte colony stimulating factor, Biochem. Biophys. Res. Comm. 159:103-111, 1989.;;Lachaux et al., Treatment with lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) and orthotopic liver transplantation for glycogen storage disease type lb, J. Ped. 123:1005-1008, 1993.;;Lange et al., Reperfusion therapy in acute myocardial infarction, N. Engl. J. Med. 346:954-955, 2002.;;Lu et al., Disulfide and secondary structures of recombinant human granulocyte colony stimulating factor, Arch. Biochem. Biophys. 268:81-92, 1989.;;Moore et al., Synergy of interleukin 1 and granulocyte colony-stimulating factor: In vivo stimulation of stem-cell recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice, Proc. Natl. Acad. Aci. USA 84:7134-7138, 1987.;;Orlic et al., Bone marrow cells regenerate infarcted myocardium, Nature (London) 410:701-705, 2001.;;Orlic et al., Mobilized bone marrow cells repair the infarcted heart, improving function and survival, Proc. Nat. Acad. Sci USA 98:10344-10347, 2001.;;Orlic et al., Adult bone marrow stem cells regenerate myocardium in ischemic heart disease, Ann. N.Y. Acad. Sci. 996: 152-157, 2003.;;Rosenthal et al., Bone marrow-derived angioblasts may be used to promote cardiac revascularization in the days following a myocardial infarction, Nature Medicine 7:412-413, 2001.;;Souza et al., Recombinant human granulocyte colony-stimulating factor: Effects on normal and leukemic myeloid cells, Science 232:61-65, 1986.;;Takano et al., Pleiotropic effects of cytokines on acute myocardial infarction: G-CSF as a novel therapy for acute myocardial infarction, Curr. Pharm. Des. 9.1121-1127, 2003.;;Welte et al., Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor, Proc. Natl. Acad. Sci. USA 82: 1526-1530, 1985.;;Wright et al., Granulocyte colony-stimulating factor (GCSF) combined with alphainterferon (alphaIFN) for treatment of liver allograft recipients with viral hepatitis, Hepatology 14:PA48, 1991.;;Ambler et al., ""Integration of bone marrow-derived stem cells into infracted myocardium following ischemia-reperfusion in mice,"" Abstract No. 413.7, FASEB Journal 17:4-5, 2003.;;Engelmann et al., ""Placebo-controlled, randomized, double-blind study on the efficacy of bone-marrow stem cell mobilization induced by granulocyte-colony stimulating factor (G-CSF) on improvement of ischemic heart failure undergoing delayed revascularization for ST segment elevation myocardial infarction (STEM),"" Abstract No. 2829, Circulation 108 (17) Suppl.:IV-622, 2003.;;Goltermann, ""Reperfusion of acute coronary syndromes and myocardial infarction,"" Air Medical Journal 19:47-49, 2000.;;Hellström-Lindberg et al., ""Treatment of anemia in myelodysplastic syndromes with granulocyte colony-stimulating factor plus erythropoietin: Results from a randomized phase II study and long-term follow-up of 71 patients,"" Blood 92:68-75, 1998.;;Kuramochi et al., ""Granulocyte-colony stimulating factor (G-CSF) administeration improves cardiac function after myocardial infarction in mice without altering cardiomyocyte regeneration,"" Abstract No. 99, Circulation, 106:19 (Suppl.): 11-20, 2002.;;Li et al., ""Efficiency of granulocyte colony stimulating factor (G-CSF) on cardiac function and cytokines in rat model acute myocardial infarction,"" Abstract No. 3P-0648, Artherosclerosis Supplements, 4 (2):204, 2003.;;Mehta et al., ""Early administration of a filgrastim following experimental myocardial infarction in a porcine ischemia reperfusion model may help myocardial repair,"" Abstract No. 4328, Blood 102:154b-155b, 2003.;;Minatoguchi et al., ""Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment,"" Circulation, 109:2572-2580, 2004.;;Minatoguchi et al., ""Myocardial infarction itself induces cardiomyocyte regeneration from bone marrow cells, and post-ischemic G-CSF treatment improves cardiac dysfunction via acceleration of the process,"" Abstract No. 666, Circulation 106 (19) Suppl.:II-132-133, 2002.;;Schwartz et al., ""Autologous stem cells for functional myocardial repair,"" Heart Failure Reviews, 8:237-245, 2003.",EXPIRED
4,US,A1,US 2007/0258945 A1,065-290-488-826-419,2007-11-08,2007,US 78418807 A,2007-04-05,US 78418807 A;;US 69457903 A,2003-10-27,G-GSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction,The present invention relates to methods of using Granulocyte Colony Stimulating Factor (G-CSF) polypeptide in conjunction with reperfusion therapy in the treatment of acute myocardial infarction or other ischemic events. This treatment can be used alone or in combination with other well-known methods of treatment.,UNIV NORTHWESTERN,MEHTA JAYESH;;SINGHAL SEEMA;;DAVIDSON CHARLES;;BEOHAR NIRAT;;BONOW ROBERT,,https://lens.org/065-290-488-826-419,Patent Application,yes,16,1,7,7,0,A61K38/193;;A61P9/10;;A61K38/193,A61K38/16;;A61K38/20;;A61K38/19;;A61K38/21;;A61K38/27;;A61P9/10,424/85.2;;424/85.4;;514/12,0,0,,,,DISCONTINUED
5,CA,A1,CA 2543481 A1,048-307-313-020-925,2005-05-19,2005,CA 2543481 A,2004-09-27,US 69457903 A;;US 2004/0031704 W,2003-10-27,G-CSF THERAPY AS AN ADJUNCT TO REPERFUSION THERAPY IN THE TREATMENT OF ACUTE MYOCARDIAL INFARCTION,,UNIV NORTHWESTERN,BONOW ROBERT;;BEOHAR NIRAT;;MEHTA JAYESH;;SINGHAL SEEMA;;DAVIDSON CHARLES,,https://lens.org/048-307-313-020-925,Patent Application,no,0,0,7,7,0,A61K38/193;;A61P9/10;;A61K38/193,A61K38/19;;A61K38/27;;A61P9/10,,0,0,,,,DISCONTINUED
6,US,A1,US 2005/0089507 A1,072-172-257-188-401,2005-04-28,2005,US 69457903 A,2003-10-27,US 69457903 A,2003-10-27,G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction,The present invention relates to methods of using Granulocyte Colony Stimulating Factor (G-CSF) polypeptide in conjunction with reperfusion therapy in the treatment of acute myocardial infarction or other ischemic events. This treatment can be used alone or in combination with other well-known methods of treatment.,MEHTA JAYESH;;SINGHAL SEEMA;;DAVIDSON CHARLES;;BEOHAR NIRAT;;BONOW ROBERT,MEHTA JAYESH;;SINGHAL SEEMA;;DAVIDSON CHARLES;;BEOHAR NIRAT;;BONOW ROBERT,NORTHWESTERN UNIVERSITY (2003-10-23),https://lens.org/072-172-257-188-401,Patent Application,yes,14,2,7,7,0,A61K38/193;;A61P9/10;;A61K38/193,A61K38/19;;A61K38/27,424/85.1;;424/85.2;;514/12,0,0,,,,EXPIRED
7,AU,A1,AU 2004/287369 A1,095-815-980-425-868,2005-05-19,2005,AU 2004/287369 A,2004-09-27,US 69457903 A;;US 2004/0031704 W,2003-10-27,G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction,,UNIV NORTHWESTERN,SINGHAL SEEMA;;BEOHAR NIRAT;;MEHTA JAYESH;;BONOW ROBERT;;DAVIDSON CHARLES,,https://lens.org/095-815-980-425-868,Patent Application,no,0,0,7,7,0,A61K38/193;;A61P9/10;;A61K38/193,A61K38/19;;A61K38/27,,0,0,,,,DISCONTINUED
